Establishing secure connection…Loading editor…Preparing document…

HR Drug Screening Policy

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

HR Drug Screening Policy

Effective Date:

Purpose

This Drug Screening Policy establishes requirements for pre-employment, reasonable suspicion, post-accident, random, return-to-duty and follow-up testing of employees and applicants to ensure a safe, healthy and productive workplace. The policy describes prohibited conduct, testing procedures, confidentiality protections, and disciplinary measures for violations.

Scope

This policy applies to all company employees, applicants, contractors, and volunteers where applicable. Covered populations include:

Applicants offered conditional employment

Current employees occupying safety-sensitive positions

Employees designated for random testing pool

Employees subject to post-accident testing

Contractors and temporary staff where contract requires

Definitions

"Positive test" means a confirmed laboratory result indicating presence of a prohibited substance at or above established cutoff concentrations. "Reasonable suspicion" means a supervisor's contemporaneous, documented observations of behavior, speech or appearance reasonably indicative of impairment. "Safety-sensitive position" means a role where impairment could reasonably result in harm to persons or property.

Policy Requirements

The Company requires drug and alcohol screening under the following circumstances:

1. Pre-employment: All applicants offered employment in covered positions must complete testing prior to the start of employment. Refusal or a positive confirmed result disqualifies the applicant from hire for the designated position.

2. Reasonable Suspicion: When a trained supervisor documents reasonable suspicion, the employee will be required to submit to immediate testing.

3. Post-Accident: Testing is required when an accident occurs that results in injury, property damage, or where impairment may have contributed to the incident.

4. Random Testing: Employees in the random pool are subject to unannounced selection and testing at a frequency determined by the Company.

5. Return-to-Duty and Follow-Up: After a confirmed positive test and successful completion of required treatment, return-to-duty testing and periodic follow-up tests will be required as a condition of continued employment.

Testing Procedures

All specimen collection will follow published chain-of-custody procedures to preserve sample integrity. Initial screening will be conducted using an immunoassay or equivalent; all non-negative results will be confirmed by a laboratory utilizing chromatographic methods and mass spectrometry when required. A Medical Review Officer (MRO) will review confirmed positive results and provide the employee an opportunity to explain or document legitimate medical use of a tested substance.

Collection Site Location (if applicable):

Substances Tested

The Company screens for a standard panel of substances. The following may be included:

Alcohol (breath or blood)

Amphetamines / Methamphetamine

Opioids (including heroin, morphine, codeine)

Cannabinoids (marijuana)

Cocaine

PCP

Benzodiazepines

Synthetic opioids and designer drugs

Refusal, Tampering and Consequences

A refusal to provide a specimen, attempt to tamper with a specimen, failure to appear for testing without a legitimate reason, or submission of a substituted or adulterated specimen shall be treated as a positive test. Disciplinary measures for a confirmed positive test or refusal may include denial of employment, paid or unpaid suspension, mandatory participation in a treatment program, reassignment, or termination consistent with company policy and applicable law.

Confidentiality and Records

Test results, treatment records, and related documentation will be maintained in secure files separate from the employee's personnel file. Access to drug and alcohol testing records is limited to those with a legitimate need to know. Records will be retained in accordance with applicable legal and regulatory requirements and Company record retention schedules.

Retention Period (years):

Assistance and Rehabilitation

Employees who test positive may be required to participate in an approved treatment or rehabilitation program as a condition of continued employment. Where applicable, the Company will consider reasonable accommodation requests in accordance with law for employees undergoing treatment.

Compliance with Law

This policy will be administered in a manner that complies with federal, state and local laws. Where legal requirements differ from this policy, the Company will apply the standard that affords the greater protection to the employee or is required by law.

Employee Acknowledgment and Information

Personal Information

Position Information

Employment History (Most Recent)

Employment History (Prior)

Education

References

Legal Disclosures

At-Will Employment Statement: Employment with the Company is on an at-will basis. Nothing in this policy or elsewhere constitutes a contract guaranteeing continued employment for any specific term, and either the employee or the Company may terminate the employment relationship at any time, with or without cause or prior notice.

Equal Opportunity Statement: The Company provides equal employment opportunity and will not discriminate on the basis of legally protected characteristics. Drug and alcohol testing will be administered uniformly and in compliance with applicable nondiscrimination requirements.

Authorization and Certification

I certify that all information provided on this form is true and complete to the best of my knowledge. I authorize the Company, its designated collection agent, and laboratory to conduct drug and alcohol testing in accordance with this policy. I further authorize release of test results and necessary medical information to the Medical Review Officer and Company officials with a legitimate need to know for the purpose of administering this policy.

Applicant/Employee Authorization to Contact Prior Employers and Conduct Background Checks: I consent to the Company contacting my previous employers and conducting background checks as necessary to verify employment history and fitness for duty.

Applicant/Employee Certification: I certify that the statements made in this acknowledgment are true and understand that falsification or omission of facts may result in disciplinary action up to and including termination.

Acknowledgement and Additional Comments

By signing below I acknowledge that I have received, read, and understand the Company Drug Screening Policy and agree to comply with its terms.

Printed Name:

Signature:

Date:

Enter text✕

What an HR Drug Screening Policy Covers

An HR Drug Screening Policy is a written employer procedure that outlines when and how workplace drug and alcohol testing is conducted, who is subject to screening, the types of tests used, and the steps for handling positive results. It explains pre-employment, reasonable suspicion, post-accident, and random testing triggers; lists consent and privacy safeguards; describes chain-of-custody and laboratory confirmation procedures; and defines disciplinary actions, rehabilitation options, and confidentiality obligations. The policy should align with federal laws, applicable state statutes, and any collective bargaining agreements.

Why a Clear Policy Matters for HR

A clear HR Drug Screening Policy reduces workplace safety risks, ensures consistent treatment of employees, and supports defensible decision-making after a positive test. It also clarifies testing triggers, minimizes discrimination claims, and helps HR meet federal and state compliance expectations.

Why a Clear Policy Matters for HR

Who Typically Uses This Policy

Common users include HR professionals, safety managers, and small business owners responsible for hiring and workplace safety.

  • Human Resources teams managing policy, testing vendors, and applicant screening processes.
  • Safety or operations managers coordinating post-incident and random testing programs.
  • Legal counsel and compliance officers advising on state law limits and confidentiality.

Use the policy as a reference for consistent decisions and as documentation in employment records.

Step-by-Step: Implementing Your Policy

Follow these steps to prepare, distribute, and enforce an HR Drug Screening Policy that aligns with law and operational needs.

  • 01
    Draft Policy: Document testing scope, procedures, and appeals process.
  • 02
    Legal Review: Have counsel confirm state law compliance and disclosure language.
  • 03
    Employee Notice: Provide written notice and obtain signed consent where required.
  • 04
    Implement Testing: Coordinate with certified lab and document chain of custody.

Quick Revision Grid for Policy Updates

Use this quick grid to revise or update the policy with clear version control and stakeholder sign-off.

01

Trigger:

Identify what event starts testing.
02

Revision Owner:

Name responsible HR or legal owner.
03

Version:

Assign sequential version number and date.
04

Stakeholder Review:

Collect feedback from HR, legal, and safety.
05

Approval:

Secure sign-off from senior HR leader.
06

Distribution:

Publish to intranet and employee handbook.

Key Components to Include in the Policy

Core components of an HR Drug Screening Policy define authority, testing methods, compliance steps, employee rights, recordkeeping, and procedures for positive results and remediation.

Scope

Detail who is covered (applicants, safety-sensitive employees, contractors), where testing applies, and any exclusions such as off-duty lawful activities or roles covered by collective bargaining agreements.

Testing Types

Specify authorized specimen types, laboratory confirmation standards, cutoff thresholds, and whether breath, saliva, hair, or blood testing is permitted in workplace settings.

Consent

Describe consent process, required disclosures, employee rights to decline where law permits, and procedures for withdrawing consent or requesting reasonable accommodation for disability or medication use.

Chain of Custody

Outline specimen handling steps, labeling, secure transport to the testing lab, documentation required at each handoff, and timelines for laboratory reporting and confirmatory testing results.

Positive Result Process

Set thresholds for positive findings, steps for notification, options for split-sample confirmation, appeal rights, return-to-duty testing, and available Employee Assistance Program or rehabilitation referrals where applicable.

Recordkeeping

Specify retention schedules, secure storage, limited access controls, redaction of medical information, and procedures for sharing records with regulators, benefiting from HIPAA-compliant handling when medical data is involved.

Security and Privacy Considerations

Confidentiality: Limit access to authorized HR and legal staff.
Encryption: TLS 1.2 and 1.3 in transit; AES-256 at rest.
Access Controls: Role-based permissions and two-factor authentications.
HIPAA BAA: Execute BAA when handling protected health information.
Audit Trail: Immutable logs with timestamps and user IDs.
Data Minimization: Collect only data necessary for testing and compliance.

Penalties and Risks of Noncompliance

Legal Liability: Wrongful termination suits.
Discrimination Claims: Claims for disparate impact.
Regulatory Fines: State penalties possible.
Operational Disruption: Lost productivity during investigations.
Data Breach Risk: PHI exposure fines.
Invalid Tests: Chain-of-custody failures.

Common Preparation Mistakes to Avoid

  • Failing to specify which employee categories are covered, leading to inconsistent application and potential discrimination claims.
  • Using ambiguous testing thresholds or unapproved specimen types without lab confirmation, which can invalidate positive results.
  • Not aligning testing procedures with state law or failing to update the policy after statutory changes.
  • Poor recordkeeping of chain-of-custody or inconsistent handling of confidential medical information, raising legal exposure risks.

How Testing Workflow Typically Operates

This section outlines where and how HR submits tests, coordinates labs, and stores results for compliance and employee records.

  • Submit to Lab: Send specimens with chain-of-custody forms.
  • Lab Confirmation: Laboratory performs initial and confirmatory testing.
  • Results Reporting: Lab reports to designated medical review officer.
  • Record Storage: Store results securely with limited access controls.

Digital Signing and eSubmission Requirements

For eSignature, ensure platform supports secure authentication, audit trails, and HIPAA protections when handling health information.

  • Authentication: Two-factor authentication required for sensitive actions.
  • Audit Trail: Detailed timestamps, IPs, and signer identity.
  • HIPAA BAA: BAA available for covered entities.

How to Configure an Online Screening Workflow

Configure online workflows to enforce testing order, signer authentication, lab notifications, and document retention automatically.

Field Configuration
Consent Form Attach as required PDF and require signature.
Signer Auth Use email plus SMS code for verification.
Notifications Auto-notify lab and HR on completed results.
Retention Set 7-year retention or per legal schedule.

Practical Examples from Real Organizations

Real-world examples show how HR teams use policy templates and eSignature to speed hiring and document retention.

Optica Ventures – COO

Optica Ventures streamlined pre-employment screening by pairing a clear drug testing policy with digital consent forms and integrated lab notifications.

  • Reduced turnaround time and administrative errors.
  • The COO reported faster onboarding and fewer data entry mistakes, and the electronic audit trail simplified investigations after incidents while preserving confidentiality and chain-of-custody documentation for compliance and legal defensibility.

Fertility Centers – Founder

Fertility Centers of Illinois used digital policies to manage sensitive health-related testing consents and to centralize records across clinical and HR systems.

  • Improved record security and access control.
  • Their founder noted better integration with case management, clearer patient-employee boundaries, and secure storage subject to HIPAA protections, reducing risk while allowing necessary workplace testing for safety-sensitive roles.

eSignature Pricing Comparison for HR Drug Screening Workflows

Compare eSignature vendors for HR Drug Screening Policy execution, focusing on price, trial availability, bulk sending, audit trail, and HIPAA support.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial Varies by plan Varies by plan Varies by plan Varies by plan
Bulk Send Yes Yes Yes Yes Varies
Audit Trail Yes Yes Yes Yes Yes
HIPAA Compliant Yes Yes Yes No No
Envelope Cap No cap 100 envelopes/user/year Varies by plan Varies by plan Varies by plan

Frequently Asked Questions About the HR Drug Screening Policy

Answers to common questions on scope, consent, testing methods, and handling positive results for HR Drug Screening Policy.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users